Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Donate

Recent Posts

  • Investing in Psychedelics, Psilocybin, or Magic Mushrooms
  • China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • Arguments Against Magic Mushrooms or Psilocybin?
  • $800 Million Valuation for First Psilocybin Company?
  • Decriminalize Denver – Initiative’s Focus on Mushrooms NOT Molecules

Recent Comments

  • Staff Scientist on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • Maxine Wilkie on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • Staff Scientist on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • J— on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • Bruce Brandy on Psilacetin and Psilocybin — Two Equivalent Means for Administering Psilocin

Archives

  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • aeruginascin
  • anxiety
  • business
  • cognitive enhancement
  • decriminalization
  • depression
  • law
  • legalization
  • mass
  • micro dosing
  • molecules vs. mushrooms
  • mushrooms
  • psilocin
  • psilocybin
  • psilocybin chemistry
  • psilocybin derivatives
  • Psilocybin Science
  • Psychedelic Science Review
  • research
  • state of the art
  • treatment
  • Uncategorized
  • unmet need
  • wood lover paralysis

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org
Copyright © 2019 Psilocybin Technology – OnePress theme by FameThemes